Qi Lv

691 total citations
25 papers, 449 citations indexed

About

Qi Lv is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qi Lv has authored 25 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qi Lv's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and RNA modifications and cancer (3 papers). Qi Lv is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and RNA modifications and cancer (3 papers). Qi Lv collaborates with scholars based in China, United States and France. Qi Lv's co-authors include Haiyun Wang, Chunhui Ma, Gangmin Wang, Jens Köhler, Pasi A. Jänne, Chiara Ambrogio, Jia Lu, Zhi-Wei Zhou, Kenneth D. Westover and Cristina Caffarra and has published in prestigious journals such as Cell, Nature Communications and Annals of Oncology.

In The Last Decade

Qi Lv

24 papers receiving 449 citations

Peers

Qi Lv
Ilenia Agliarulo Italy
Zining Jin China
Valérie Vial France
Sara Faouzi France
Yi‐Fang Yang Taiwan
Liyun Luo China
Ailan Cheng China
Mesquita Rodrigues Portugal
Yi Su China
Ilenia Agliarulo Italy
Qi Lv
Citations per year, relative to Qi Lv Qi Lv (= 1×) peers Ilenia Agliarulo

Countries citing papers authored by Qi Lv

Since Specialization
Citations

This map shows the geographic impact of Qi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Lv more than expected).

Fields of papers citing papers by Qi Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Lv. The network helps show where Qi Lv may publish in the future.

Co-authorship network of co-authors of Qi Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Lv. A scholar is included among the top collaborators of Qi Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Lv. Qi Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cai, Gang, Keman Liao, Jian Yang, et al.. (2025). Targeting PGE2 mediated senescent neuron improves tumor therapy. Neuro-Oncology. 27(6). 1491–1506. 1 indexed citations
3.
Lv, Qi, Keman Liao, Lu Cao, et al.. (2025). Chemotherapeutic drug-triggered AEP-cleaved G3BP1 orchestrates stress granules/nucleoli/mitochondria in osteosarcoma. Bone Research. 13(1). 74–74. 1 indexed citations
4.
Chen, Bin, et al.. (2025). Chemotactic Zn micromotor for treatment of high blood ammonia-associated hepatic encephalopathy. Nature Communications. 16(1). 4525–4525. 1 indexed citations
5.
Lv, Qi, Xiang Zhao, Songsong Teng, et al.. (2025). DNA Origami‐Based CD44‐Targeted Therapy Silences Stat3 Enhances Cartilage Regeneration and Alleviates Osteoarthritis Progression. Advanced Science. 12(29). e03939–e03939. 3 indexed citations
6.
Yi, Hong, Tianyi Zhu, Shuang Qin, et al.. (2024). Circular RNA circAGAP1 promotes sunitinib sensitivity in renal cell carcinoma via sponging multiple PDGFR-targeted miRNAs. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 33(2). 407–420. 2 indexed citations
7.
Shen, Aijun, Gangmin Wang, Xianfu Meng, et al.. (2023). An Adaptable Nanoprobe Integrated with Quantitative T 1 ‐Mapping MRI for Accurate Differential Diagnosis of Multidrug‐Resistant Lung Cancer. Advanced Healthcare Materials. 12(31). e2300684–e2300684. 3 indexed citations
8.
Chen, Binghong, Mengying Wang, Junjun Qiu, et al.. (2022). Cleavage of tropomodulin-3 by asparagine endopeptidase promotes cancer malignancy by actin remodeling and SND1/RhoA signaling. Journal of Experimental & Clinical Cancer Research. 41(1). 209–209. 16 indexed citations
9.
Xu, Jichong, et al.. (2021). Drug-eluting bead transarterial chemoembolization (TACE) exhibits superior efficacy and equal tolerance to conventional TACE in hepatocellular carcinoma patients with conventional TACE history. Clinics and Research in Hepatology and Gastroenterology. 46(3). 101814–101814. 5 indexed citations
10.
Lv, Qi, Gangmin Wang, Yinan Zhang, et al.. (2021). CircAGAP1 promotes tumor progression by sponging miR-15-5p in clear cell renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 76–76. 23 indexed citations
11.
Chen, Binghong, Mengying Wang, Keman Liao, et al.. (2021). Circular RNA circLGMN facilitates glioblastoma progression by targeting miR-127-3p/LGMN axis. Cancer Letters. 522. 225–237. 32 indexed citations
12.
Lv, Qi, Chunhui Ma, Haoming Li, et al.. (2020). Circular RNA microarray expression profile and potential function of circ0005875 in clear cell renal cell carcinoma. Journal of Cancer. 11(24). 7146–7156. 19 indexed citations
13.
Wang, Haiyun, Qi Lv, Yue Xu, et al.. (2019). An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer. EBioMedicine. 49. 106–117. 21 indexed citations
14.
Zheng, Zixuan, Guanghua Wang, Dianwen Song, et al.. (2019). The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma With Bone Metastasis. Frontiers in Bioengineering and Biotechnology. 7. 257–257. 22 indexed citations
15.
Wang, Haiyun, Qi Lv, Yue Xu, et al.. (2019). An Integrative Pharmacogenomics Analysis Identifies Therapeutic Targets in KRAS-Mutant Lung Cancer. SSRN Electronic Journal. 1 indexed citations
16.
Lv, Qi, Gangmin Wang, Yinan Zhang, et al.. (2019). FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway. International Journal of Oncology. 54(4). 1221–1232. 48 indexed citations
17.
Ambrogio, Chiara, Jens Köhler, Zhi-Wei Zhou, et al.. (2018). KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS. Cell. 172(4). 857–868.e15. 188 indexed citations
18.
Ambrogio, Chiara, Jens Köhler, Zhi Zhou, et al.. (2017). Wild-type KRAS mediates growth inhibition and resistance to MEK inhibitors through dimerization with mutant KRAS in lung adenocarcinoma. Annals of Oncology. 28. v1–v1. 3 indexed citations
19.
Ambrogio, Chiara, Jens Köhler, Zhi Zhou, et al.. (2017). P3.02-066 Wild-Type KRAS Mediates Growth Inhibition and Resistance to MEK Inhibitors through Dimerization with Mutant KRAS in Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(11). S2261–S2261. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilenia Agliarulo Breakdown of academic impact, for papers by Zining Jin Breakdown of academic impact, for papers by Valérie Vial Breakdown of academic impact, for papers by Sara Faouzi Breakdown of academic impact, for papers by Yi‐Fang Yang Breakdown of academic impact, for papers by Liyun Luo Breakdown of academic impact, for papers by Ailan Cheng Breakdown of academic impact, for papers by Mesquita Rodrigues Breakdown of academic impact, for papers by Yi Su
Rankless by CCL
2026